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Introduction
This is a case report of a 15 year old girl which presented
with Pyrexia of Unknown Origin. She was initially treated
for possible sepsis and then received treatment for
Atypical Kawasaki’s. She was subsequently investigated
for Haemophagocytic Lymphohistiocytosis (HLH). She
was eventually diagnosed with Systemic Juvenile Idio-
pathic Arthritis (SoJIA) complicated with Macrophage
Activation Syndrome (MAS) at presentation and was
commenced on Methotrexate.
Objectives
This case report highlights the difficulties in distinguish-
ing inflammatory conditions at first presentation.
Methods
The case was derived from a retrospective review of case
notes and laboratory findings. The patient was managed
at two sites, a district hospital paediatric unit and a ter-
tiary rheumatology centre. All authors have been
involved in the medical management of the patient.
Results
A previously well 15 year-old girl presented with two
week history of fever, rash, poor appetite, weight loss and
multiple joint pain and swelling. She was found to have a
non-specific rash, migratory synovitis, muscle weakness,
cervical and axillary lymphadenopathy and splenomegaly.
Blood investigations had shown anaemia, neutrophilia,
thrombocytosis, raised inflammatory markers (CRP, ESR,
Ferritin), and deranged liver and muscle enzymes. She
was treated initially with broad spectrum IV antibiotics.
Infection screen was negative as well as serology for
ASOT, anti-Dnase B Streptococcal, EBV, CMV and HIV.
In view of persistent pyrexia, lymphadenopathy and rash
a diagnosis of Atypical Kawasaki’s was made and IV
Immunoglobulins were given. Baseline Echocardiogram
was normal, abdominal ultrasound confirmed splenome-
galy and CT showed evidence of bilateral pleural effu-
sions and a large axillary lymph node.
In view of on-going symptoms she was transferred to
a Tertiary unit for further investigations. A diagnosis of
Secondary HLH was considered in view of on-going
fever, rash, lymphadenopathy, splenomegaly, very high
ferritin (160,000), high triglycerides and high SCL25
(IL-2R). A bone marrow was inconclusive and no Per-
forin mutations were identified. She was treated with
high dose anti-inflammatories and by the 6th week of
her illness her systemic symptoms and rash have sub-
sided however she continued to have persistent synovi-
tis and splenomegaly. A diagnosis of SoJIA was made
and was treated with two IV Methyl Prednisolone
pulses, intra-articular steroids and commenced on
Methotrexate. Following six weeks of Methotrexate all
her symptoms had resided and all inflammatory mar-
kers were back to normal. As she was intolerant to
Methotrexate it was decided to stop treatment. She has
remained well since.
Conclusion
Secondary HLH can be trigger by infections usually
EBV, CMV, parvovirus, herpes simplex, varicella-zoster,
measles as well as human herpes virus-8 and HIV infec-
tion. In our case no infection trigger was identified how-
ever our patient met the defined set of Diagnostic
criteria1. In a new presentation, it is often difficult to
make a distinction between infection triggered HLH and
a new presentation of systemic JIA complicated with
MAS. Early recognition is important and treatment
should be initiated promptly.
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